We report here, for the first time, the comparison of CTC with different serum tumor markers (CEA, CA 15-3, CYFRA 21-1) and non-tumor markers (lactate deshydrogenase LDH, alkaline phosphatase ALP), which was a prospectively planned secondary objective of the IC 2006-04 study. This evidence concerns the gene CEACAM5 and neoplasm.